Bottom line
What does GNOM hold?
GNOM held 51 positions as of May 31, 2026. Its largest holding is Guardant Health, Inc. at 5.59% of the fund, and the top 10 positions add up to 42.5%. By asset type it is 100% stocks, 3% repurchase agreements.
Updated Jul 29, 2026
GNOM top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Guardant Health, Inc. GUARDANT HEALTH INC COMMON STOCK |
Stocks | 5.59% | $3.1M |
| 2 | Illumina, Inc. ILLUMINA INC COMMON STOCK |
Stocks | 4.82% | $2.7M |
| 3 | Natera, Inc. NATERA INC COMMON STOCK |
Stocks | 4.15% | $2.3M |
| 4 | Biomarin Pharmaceutical Inc. BIOMARIN PHARMACEUTICAL INC COMMON STOCK |
Stocks | 4.09% | $2.3M |
| 5 | Arrowhead Pharmaceuticals, Inc. ARROWHEAD PHARMACEUTICALS IN COMMON STOCK |
Stocks | 4.07% | $2.3M |
| 6 | Legend Biotech Corp LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT |
Stocks | 4.05% | $2.3M |
| 7 | Praxis Precision Medicines Inc PRAXIS PRECISION MEDICINES I COMMON STOCK |
Stocks | 4.01% | $2.2M |
| 8 | Twist Bioscience Corp TWIST BIOSCIENCE CORP COMMON STOCK |
Stocks | 3.97% | $2.2M |
| 9 | Vertex Pharmaceuticals Incorporated VERTEX PHARMACEUTICALS INC COMMON STOCK |
Stocks | 3.95% | $2.2M |
| 10 | CRISPR Therapeutics AG CRISPR THERAPEUTICS AG COMMON STOCK |
Stocks | 3.85% | $2.1M |
| 11 | Veracyte Inc VERACYTE INC COMMON STOCK |
Stocks | 3.64% | $2.0M |
| 12 | Qiagen N.V. QIAGEN N.V. COMMON STOCK |
Stocks | 3.54% | $2.0M |
| 13 | BioNTech SE BIONTECH SE-ADR DEPOSITARY RECEIPT |
Stocks | 3.41% | $1.9M |
| 14 | Bio-techne Corporation BIO-TECHNE CORP COMMON STOCK |
Stocks | 3.41% | $1.9M |
| 15 | Moderna, Inc. MODERNA INC COMMON STOCK |
Stocks | 3.28% | $1.8M |
| 16 | 10X Genomics Inc 10X GENOMICS INC-CLASS A COMMON STOCK |
Stocks | 3.23% | $1.8M |
| 17 | Beam Therapeutics Inc BEAM THERAPEUTICS INC COMMON STOCK |
Stocks | 3.09% | $1.7M |
| 18 | Bnyrepos | Repurchase agreements | 3.05% | $1.7M |
| 19 | Eli Lilly And Company ELI LILLY & CO COMMON STOCK |
Stocks | 2.32% | $1.3M |
| 20 | Ultragenyx Pharmaceutical Inc ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK |
Stocks | 2.25% | $1.3M |
| 21 | Caris Life Sciences, Inc. CARIS LIFE SCIENCES INC COMMON STOCK |
Stocks | 2.03% | $1.1M |
| 22 | Genscript Biotech Corp GENSCRIPT BIOTECH CORP COMMON STOCK |
Stocks | 2.00% | $1.1M |
| 23 | BillionToOne Inc BILLIONTOONE INC CL A COMMON STOCK |
Stocks | 1.97% | $1.1M |
| 24 | Gilead Sciences, Inc. GILEAD SCIENCES INC COMMON STOCK |
Stocks | 1.95% | $1.1M |
| 25 | Astrazeneca Plc ASTRAZENECA PLC COMMON STOCK |
Stocks | 1.83% | $1.0M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026